From: Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema
Cost (€) | Incremental cost (€) | Efficacy (QALYs) | Incremental efficacy (QALYs) | ICER (€/QALY) | |
---|---|---|---|---|---|
Aflibercept | 92,340 | – | 4.134 | – | – |
Dexamethasone | 169,689 | 77,349 | 6.80 | 2.667 | 29.002 |